ARTHROPLASTY
TKR: No difference between oxidized zirconium and cobalt-chromium femoral components
J Bone Joint Surg Br. 2012 Sep;94(9):1221-7351 patients (701 knees) with osteoarthritis underwent simultaneous bilateral total knee replacement (TKR), in which each knee was randomized to receive an oxidised zirconium (OxZr) or a cobalt-chrome (CoCr) femoral component. After a mean of 7.5 years, there was no significant difference between the two groups for mean weight, size, and shape of the aspirated wear particles. The two groups also did not differ in pain, function ratings, range of movement, and satisfaction with treatment. Since the OxZr component costs more than the CoCr component, it can be concluded that the CoCr femoral component is most suitable for patients with osteoarthritis undergoing TKR following this mid-term assessment.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
